| 1 |
Collatuzzo G, La Vecchia C, Parazzini F, Alicandro G, Turati F, Di Maso M, Malvezzi M, Pelucchi C, Negri E, Boffetta P. Cancers attributable to infectious agents in Italy. Eur J Cancer 2023;183:69-78. [PMID: 36801622 DOI: 10.1016/j.ejca.2023.01.010] [Reference Citation Analysis]
|
| 2 |
Park E, Nishimura M, Simoes P. Endoscopic advances in the management of gastric cancer and premalignant gastric conditions. World J Gastrointest Endosc 2023; 15(3): 114-121 [DOI: 10.4253/wjge.v15.i3.114] [Reference Citation Analysis]
|
| 3 |
liu G, Li X, Shen X. Lumican promotes proliferation, migration and invasion of gastric cancer through ERK pathway.. [DOI: 10.21203/rs.3.rs-2679516/v1] [Reference Citation Analysis]
|
| 4 |
Ji B, Qiao L, Zhai W. CGB5, INHBA and TRAJ19 Hold Prognostic Potential as Immune Genes for Patients with Gastric Cancer. Dig Dis Sci 2023;68:791-802. [PMID: 35624327 DOI: 10.1007/s10620-022-07513-9] [Reference Citation Analysis]
|
| 5 |
Su J, Thakur A, Pan G, Yan J, Gaurav I, Thakur S, Yang Z, Cili A, Zhang K. Morus alba derived Kuwanon: A combined with 5‐fluorouracil reduce tumor progression via synergistic activation of GADD153 in gastric cancer. MedComm – Oncology 2023;2. [DOI: 10.1002/mog2.24] [Reference Citation Analysis]
|
| 6 |
Chen J, Hai Y, Hu Q, Chen C, Jiang X, Gao Y. TGF-β Signaling Activation Confers Anlotinib Resistance in Gastric Cancer. Pharm Res 2023;40:689-99. [PMID: 36539669 DOI: 10.1007/s11095-022-03461-1] [Reference Citation Analysis]
|
| 7 |
Ivanović T, Božić D, Benzon B, Čapkun V, Vukojević K, Glavina Durdov M. Histological Type, Cytotoxic T Cells and Macrophages in the Tumor Microenvironment Affect the PD-L1 Status of Gastric Cancer. Biomedicines 2023;11:709. [DOI: 10.3390/biomedicines11030709] [Reference Citation Analysis]
|
| 8 |
Manfredi M, Gismondi P, Iuliano S. Is Helicobacter pylori Anyway Pathogen in Children? Inquiry 2023;60:469580231154650. [PMID: 36803205 DOI: 10.1177/00469580231154650] [Reference Citation Analysis]
|
| 9 |
Shang F, Wang Y, Shi Z, Deng Z, Ma J. Development of a Signature Based on Eight Metastatic-Related Genes for Prognosis of GC Patients. Mol Biotechnol 2023. [PMID: 36790659 DOI: 10.1007/s12033-023-00671-9] [Reference Citation Analysis]
|
| 10 |
Rojas A, Lindner C, Schneider I, González I, Morales MA. Contributions of the receptor for advanced glycation end products axis activation in gastric cancer. World J Gastroenterol 2023; 29(6): 997-1010 [DOI: 10.3748/wjg.v29.i6.997] [Reference Citation Analysis]
|
| 11 |
Khairan P, Sobue T, Eshak ES, Kitamura T, Iwasaki M, Inoue M, Yamaji T, Iso H, Tsugane S, Sawada N. Sugary drink consumption and the subsequent risk of gastric cancer: The Japan Public Health Center-based Prospective Study. Eur J Clin Nutr 2023;77:218-25. [PMID: 36167978 DOI: 10.1038/s41430-022-01216-0] [Reference Citation Analysis]
|
| 12 |
Huangfu L, Wang X, Tian S, Chen J, Wang X, Fan B, Yao Q, Wang G, Chen C, Han J, Xing X, Ji J. Piceatannol enhances Beclin-1 activity to suppress tumor progression and its combination therapy strategy with everolimus in gastric cancer. Sci China Life Sci 2023;66:298-312. [PMID: 36271983 DOI: 10.1007/s11427-022-2185-9] [Reference Citation Analysis]
|
| 13 |
Yang H, Mou Y, Hu B. Discussion on the common controversies of Helicobacter pylori infection. Helicobacter 2023;28:e12938. [PMID: 36436202 DOI: 10.1111/hel.12938] [Reference Citation Analysis]
|
| 14 |
He L, Li Y, Qu L, Zhang F. Prognostic and clinicopathological value of the geriatric nutritional risk index in gastric cancer: A meta-analysis of 5,834 patients. Front Surg 2022;9:1087298. [PMID: 36684163 DOI: 10.3389/fsurg.2022.1087298] [Reference Citation Analysis]
|
| 15 |
Jia R, Guo X, Liu H, Zhao F, Fan Z, Wang M, Sui J, Yin B, Wang Z, Wang Z. Analysis of Staged Features of Gastritis-Cancer Transformation and Identification of Potential Biomarkers in Gastric Cancer. J Inflamm Res 2022;15:6857-68. [PMID: 36597437 DOI: 10.2147/JIR.S390448] [Reference Citation Analysis]
|
| 16 |
Dong R, Chen S, Lu F, Zheng N, Peng G, Li Y, Yang P, Wen H, Qiu Q, Wang Y, Wu H, Liu M. Models for Predicting Response to Immunotherapy and Prognosis in Patients with Gastric Cancer: DNA Damage Response Genes. Biomed Res Int 2022;2022:4909544. [PMID: 36578802 DOI: 10.1155/2022/4909544] [Reference Citation Analysis]
|
| 17 |
Chang J, Wu Y, Zhou S, Tian Y, Wang Y, Tian J, Song W, Dong Y, Li J, Zhao Z, Che G. Genetically predicted testosterone and cancers risk in men: a two-sample Mendelian randomization study. J Transl Med 2022;20:573. [PMID: 36482455 DOI: 10.1186/s12967-022-03783-z] [Reference Citation Analysis]
|
| 18 |
Kong S, Li Z, Wang Y, Zhang Z, Jia X, Gao X, Cong B, Zhang F, Zhang J, Zheng C. A Wnt-related gene expression signature to improve the prediction of prognosis and tumor microenvironment in gastric cancer. Front Genet 2022;13:1035099. [PMID: 36561311 DOI: 10.3389/fgene.2022.1035099] [Reference Citation Analysis]
|
| 19 |
Kuramoto J, Arai E, Fujimoto M, Tian Y, Yamada Y, Yotani T, Makiuchi S, Tsuda N, Ojima H, Fukai M, Seki Y, Kasama K, Funahashi N, Udagawa H, Nammo T, Yasuda K, Taketomi A, Kanto T, Kanai Y. Quantification of DNA methylation for carcinogenic risk estimation in patients with non-alcoholic steatohepatitis. Clin Epigenetics 2022;14:168. [PMID: 36471401 DOI: 10.1186/s13148-022-01379-4] [Reference Citation Analysis]
|
| 20 |
Li F, Li S, Wang X, Liu C, Li X, Li Y, Liu Y. To investigate the prognostic factors of stage Ⅰ-Ⅱ gastric cancer based on P53 mutation and tumor budding. Pathol Res Pract 2022;240:154195. [PMID: 36356333 DOI: 10.1016/j.prp.2022.154195] [Reference Citation Analysis]
|
| 21 |
Li H, Xue S, Zhang X, Li F, Bei S, Feng L. CircRNA PVT1 modulated cell migration and invasion through Epithelial-Mesenchymal Transition (EMT) mediation in gastric cancer through miR-423-5p/Smad3 pathway. Regenerative Therapy 2022;21:25-33. [DOI: 10.1016/j.reth.2022.02.003] [Reference Citation Analysis]
|
| 22 |
Gonçalves WGE, Santos MHPD, Brito LM, Palheta HGA, Lobato FMF, Demachki S, Ribeiro-Dos-Santos Â, Araújo GS. DeepHP: A New Gastric Mucosa Histopathology Dataset for Helicobacter pylori Infection Diagnosis. Int J Mol Sci 2022;23. [PMID: 36498907 DOI: 10.3390/ijms232314581] [Reference Citation Analysis]
|
| 23 |
Maddineni G, Xie JJ, Brahmbhatt B, Mutha P. Diet and carcinogenesis of gastric cancer. Curr Opin Gastroenterol 2022;38:588-91. [PMID: 36165035 DOI: 10.1097/MOG.0000000000000875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 24 |
Zeng Q, Yang J, Wang Z, Liu H, Wang J, Yang T, Hu J, Guan H, Lu Y, Liu H, Hong F. The Epidemiological Characteristics of Noncommunicable Diseases and Malignant Tumors in Guiyang, China: Cross-sectional Study. JMIR Public Health Surveill 2022;8:e36523. [DOI: 10.2196/36523] [Reference Citation Analysis]
|
| 25 |
Yang H, Guan L, Hu B, Moreira L. Detection and Treatment of Helicobacter pylori: Problems and Advances. Gastroenterology Research and Practice 2022;2022:1-10. [DOI: 10.1155/2022/4710964] [Reference Citation Analysis]
|
| 26 |
Mesquita FP, Souza PFN, da Silva EL, Lima LB, de Oliveira LLB, Moreira-nunes CA, Zuercher WJ, Burbano RMR, de Moraes MEA, Montenegro RC. Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric Cancer. Pharmaceutics 2022;14:1841. [DOI: 10.3390/pharmaceutics14091841] [Reference Citation Analysis]
|
| 27 |
Spolverato G, Capelli G, Mari V, Lorenzoni G, Gregori D, Poultsides G, Fields RC, Weber SM, Votanopoulos K, Cho CS, He J, Maithel SK, Pucciarelli S, Pawlik TM. Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma. Ann Surg Oncol 2022. [PMID: 36018525 DOI: 10.1245/s10434-022-12434-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 28 |
Li C, Wang M, Cheng X, Jiang Y, Xiao H. Nerve invasion as an independent predictor of poor prognosis in gastric cancer after curative resection. Medicine (Baltimore) 2022;101:e30084. [PMID: 35984131 DOI: 10.1097/MD.0000000000030084] [Reference Citation Analysis]
|
| 29 |
Li Y, Li T, Chen J, Zheng H, Li Y, Chu F, Wang S, Li P, Lin J, Su Z, Ding X. Manpixiao Decoction Halted the Malignant Transformation of Precancerous Lesions of Gastric Cancer: From Network Prediction to In-Vivo Verification. Front Pharmacol 2022;13:927731. [DOI: 10.3389/fphar.2022.927731] [Reference Citation Analysis]
|
| 30 |
Chophel T, Tshering S, Dorji N, Tshomo U. Stomach Cancer Screening Services of Bhutan. Indian J Surg 2022;:1-6. [PMID: 35912395 DOI: 10.1007/s12262-022-03519-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Xie W, Yang T, Zuo J, Ma Z, Yu W, Hu Z, Song Z. Chinese and Global Burdens of Gastrointestinal Cancers From 1990 to 2019. Front Public Health 2022;10:941284. [DOI: 10.3389/fpubh.2022.941284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Song Y, Liu X, Cheng W, Li H, Zhang D. The global, regional and national burden of stomach cancer and its attributable risk factors from 1990 to 2019. Sci Rep 2022;12:11542. [PMID: 35798837 DOI: 10.1038/s41598-022-15839-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 33 |
He Z, Li D, Xu Y, Wang H, Gao J, Zhang Z, Chen K. Prognostic significance of metastatic lymph node ratio in patients with gastric cancer after curative gastrectomy: a single-center retrospective study. Scand J Gastroenterol 2022;57:832-41. [PMID: 35293268 DOI: 10.1080/00365521.2022.2036807] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 34 |
Ding C, Zhang Q, Jiang X, Wei D, Xu S, Li Q, Wu M, Wang H. The Analysis of Potential Diagnostic and Therapeutic Targets for the Occurrence and Development of Gastric Cancer Based on Bioinformatics. Comput Math Methods Med 2022;2022:4321466. [PMID: 35756405 DOI: 10.1155/2022/4321466] [Reference Citation Analysis]
|
| 35 |
Zheng P, Gao H, Xie X, Lu P. Plasma Exosomal hsa_circ_0015286 as a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer. Pathol Oncol Res 2022;28:1610446. [PMID: 35755416 DOI: 10.3389/pore.2022.1610446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 36 |
Duan K, Li D, Shi D, Pei J, Ren J, Li W, Dong A, Chen T, Zhou J. Risk Factors and Timing of Additional Surgery after Noncurative ESD for Early Gastric Cancer. Can J Gastroenterol Hepatol 2022;2022:3421078. [PMID: 35775069 DOI: 10.1155/2022/3421078] [Reference Citation Analysis]
|
| 37 |
Wang L, Chang C, Cheng C, Liang Y, Pei D, Sun J, Chen Y. MCRS1 Expression Regulates Tumor Activity and Affects Survival Probability of Patients with Gastric Cancer. Diagnostics 2022;12:1502. [DOI: 10.3390/diagnostics12061502] [Reference Citation Analysis]
|
| 38 |
Zhang C, Hu A, Li J, Zhang F, Zhong P, Li Y, Li Y. Combined Non-Invasive Prediction and New Biomarkers of Oral and Fecal Microbiota in Patients With Gastric and Colorectal Cancer. Front Cell Infect Microbiol 2022;12:830684. [PMID: 35663463 DOI: 10.3389/fcimb.2022.830684] [Reference Citation Analysis]
|
| 39 |
Dai L, Wang X, Bai T, Liu J, Chen B, Yang W. Cellular Senescence-Related Genes: Predicting Prognosis in Gastric Cancer. Front Genet 2022;13:909546. [DOI: 10.3389/fgene.2022.909546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Bao W, Zhu Z, Gao Y, Chen J. Transcriptome Profiling Analysis Identifies LCP1 as a Contributor for Chidamide Resistance in Gastric Cancer. Pharm Res 2022. [PMID: 35578065 DOI: 10.1007/s11095-022-03291-1] [Reference Citation Analysis]
|
| 41 |
Razuka-ebela D, Polaka I, Daugule I, Parshutin S, Santare D, Ebela I, Rudzite D, Vangravs R, Herrero R, Young Park J, Leja M. Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study. Diagnostics 2022;12:1166. [DOI: 10.3390/diagnostics12051166] [Reference Citation Analysis]
|
| 42 |
Aziz SJ, Jalal JA, Hamadameen KS. Stromal CD10 expression in gastric adenocarcinoma. J Med Life 2022;15:679-84. [PMID: 35815076 DOI: 10.25122/jml-2021-0244] [Reference Citation Analysis]
|
| 43 |
Zebardast A, Latifi T, shirzad M, Goodarzi G, Ebrahimi Fana S, Samavarchi Tehrani S, Yahyapour Y. Critical involvement of circular RNAs in virus-associated cancers. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.04.009] [Reference Citation Analysis]
|
| 44 |
Koopaie M, Ghafourian M, Manifar S, Younespour S, Davoudi M, Kolahdooz S, Shirkhoda M. Evaluation of CSTB and DMBT1 expression in saliva of gastric cancer patients and controls. BMC Cancer 2022;22:473. [PMID: 35488257 DOI: 10.1186/s12885-022-09570-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 45 |
Zhang Y, Liu C, Ma X, Xu L, Wang X, Wang X, Cao J, Ma A, Gao T. Effect of Dietary Modification on Gastric Mucosa, Gastrointestinal Symptoms and Nutritional Status of Patients With Early Gastric Cancer After Endoscopic Submucosal Dissection Surgery: A Retrospective Cohort Study. Front Nutr 2022;9:741630. [DOI: 10.3389/fnut.2022.741630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 46 |
Jiang F, Hu X, Cao H, Shen X. Hsa_circ_0000081 promotes the function of gastric cancer through sponging hsa-miR-423-5p to influence 3-phosphoinositide-dependent kinase 1 expression. Bioengineered 2022;13:8277-90. [PMID: 35302432 DOI: 10.1080/21655979.2022.2053796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 47 |
Wang L, Guo Z, Guo B, Gao F, Liu X, Xu Y, Wang Y, Jain DK. CircNR3C1 Alleviates Gastric Cancer Development by Inactivating AKT/mTOR. Journal of Healthcare Engineering 2022;2022:1-6. [DOI: 10.1155/2022/8402732] [Reference Citation Analysis]
|
| 48 |
Chivu-Economescu M, Necula LG, Matei L, Dragu D, Bleotu C, Sorop A, Herlea V, Dima S, Popescu I, Diaconu CC. Collagen Family and Other Matrix Remodeling Proteins Identified by Bioinformatics Analysis as Hub Genes Involved in Gastric Cancer Progression and Prognosis. Int J Mol Sci 2022;23:3214. [PMID: 35328635 DOI: 10.3390/ijms23063214] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 49 |
Zhang X, Dai X, Zhao X, Wang J, Dou J, Zhuang H, Chen N, Zhao H. MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting Glycerophosphodiester Phosphodiesterase Domain Containing 5 (GDPD5) in gastric cancer cells. Bioengineered 2022;13:7082-104. [PMID: 35282764 DOI: 10.1080/21655979.2022.2045831] [Reference Citation Analysis]
|
| 50 |
Guo C, Liu Z, Yu Y, Liu S, Ma K, Ge X, Xing Z, Lu T, Weng S, Wang L, Liu L, Hua Z, Han X, Li Z. Integrated Analysis of Multi-Omics Alteration, Immune Profile, and Pharmacological Landscape of Pyroptosis-Derived lncRNA Pairs in Gastric Cancer. Front Cell Dev Biol 2022;10:816153. [DOI: 10.3389/fcell.2022.816153] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 51 |
Zhou H, Li M, Koundal D. The Value of Gastric Cancer Staging by Endoscopic Ultrasonography Features in the Diagnosis of Gastroenterology. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/6192190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 52 |
Yang Q, Chen Y, Guo R, Dai Y, Tang L, Zhao Y, Wu X, Li M, Du F, Shen J, Yi T, Xiao Z, Wen Q. Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification. Front Oncol 2021;11:822745. [PMID: 35155211 DOI: 10.3389/fonc.2021.822745] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 53 |
Liu Z, Hu K, Wang X, Zhang Y, Wang W, Wu Y. lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells. Open Medicine 2022;17:266-79. [DOI: 10.1515/med-2021-0406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 54 |
Gong Y, Jiao Y, Qi X, Fu J, Qian J, Zhu J, Yang H, Tang L. Construction of a circRNA-miRNA-mRNA network based on differentially co-expressed circular RNA in gastric cancer tissue and plasma by bioinformatics analysis. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02503-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 55 |
Zagari RM, Romano M, Frazzoni L, Marasco G, Dajti E, Arcidiacono PG, Armuzzi A, Biagi F, Cannizzaro R, Cavestro GM, Ciacci C, Monica F, Peralta S, Radaelli F, Bazzoli F. Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMAD. Helicobacter 2022;27:e12862. [PMID: 34766392 DOI: 10.1111/hel.12862] [Reference Citation Analysis]
|
| 56 |
Yang H, Hu B. Letter: the hidden reasons of long-term risk of upper gastrointestinal bleeding after Helicobacter pylori eradication. Aliment Pharmacol Ther 2022;55:372-3. [PMID: 35040165 DOI: 10.1111/apt.16736] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 57 |
Qin H, Li X, Zhang W, Ding Z. LncRNA OGFRP1 promotes cell proliferation and suppresses cell radiosensitivity in gastric cancer by targeting the miR-149-5p/MAP3K3 axis. J Mol Histol. [DOI: 10.1007/s10735-022-10058-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 58 |
Thrastardottir TO, Copeland VJ, Constantinou C. The Association Between the Gut Microbiome, Nutritional Habits, Antibiotics, and Gastric Cancer: a Scoping Review. Curr Nutr Rep 2022. [PMID: 35020173 DOI: 10.1007/s13668-021-00391-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 59 |
Feng H, Zhang H, Yan Z. Clinicopathological significance and prognostic value of P27 expression in gastric cancer patients: a meta-analysis. Anticancer Drugs 2022;33:e692-9. [PMID: 34486533 DOI: 10.1097/CAD.0000000000001240] [Reference Citation Analysis]
|
| 60 |
Prasad D, Prabhavathi V, Santosh Sushma P, Sai Babu M, Aruna P, Khan IA. Role of Circulating MicroRNAs in Prognosis and Diagnosis of Cancers. Role of MicroRNAs in Cancers 2022. [DOI: 10.1007/978-981-16-9186-7_7] [Reference Citation Analysis]
|
| 61 |
Torroni L, Vesentini R, Crocetti E, Verlato G. Epidemiology and Risk Stratification in Gastric Cancer. Gastric Cancer: the 25-year R-Evolution 2022. [DOI: 10.1007/978-3-030-73158-8_1] [Reference Citation Analysis]
|
| 62 |
Tuo JY, Bi JH, Yuan HY, Jiang YF, Ji XW, Li HL, Xiang YB. Trends of stomach cancer survival: A systematic review of survival rates from population-based cancer registration. J Dig Dis 2022;23:22-32. [PMID: 34821032 DOI: 10.1111/1751-2980.13070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 63 |
Zhu K, Yang J, Zhu H, Wang Q. Diagnostic value of exosome derived long noncoding RNA in gastric cancer in Chinese population: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e28153. [PMID: 34941064 DOI: 10.1097/MD.0000000000028153] [Reference Citation Analysis]
|
| 64 |
Chen W, Zhou Y, Wu G, Sun P. CCNI2 promotes the progression of human gastric cancer through HDGF. Cancer Cell Int 2021;21:661. [PMID: 34895232 DOI: 10.1186/s12935-021-02352-6] [Reference Citation Analysis]
|
| 65 |
Liu X, Wang S, Li J, Zhang J, Liu D. Regulatory effect of traditional Chinese medicines on signaling pathways of process from chronic atrophic gastritis to gastric cancer. Chinese Herbal Medicines 2021. [DOI: 10.1016/j.chmed.2021.10.008] [Reference Citation Analysis]
|
| 66 |
Hu F, Rao M, Zhang M, Meng Q, Wan M, Zhang X, Ding L, Jiang Y. Long non-coding RNA profiles in plasma exosomes of patients with gastric high-grade intraepithelial neoplasia. Exp Ther Med 2022;23:1. [PMID: 34815753 DOI: 10.3892/etm.2021.10923] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 67 |
Wei J, Zeng Y, Gao X, Liu T. A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer. BMC Cancer 2021;21:1221. [PMID: 34774009 DOI: 10.1186/s12885-021-08975-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 68 |
Yin H, Guo R, Zhang H, Liu S, Gong Y, Yuan Y. A Dynamic Transcriptome Map of Different Tissue Microenvironment Cells Identified During Gastric Cancer Development Using Single-Cell RNA Sequencing. Front Immunol 2021;12:728169. [PMID: 34745098 DOI: 10.3389/fimmu.2021.728169] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 69 |
Zhao Y, Huang HX, Tang SY, Sun YZ. RNA-Seq Analysis Reveals Dendrobium officinale Polysaccharides Inhibit Precancerous Lesions of Gastric Cancer through PER3 and AQP4. Evid Based Complement Alternat Med 2021;2021:3036504. [PMID: 34721627 DOI: 10.1155/2021/3036504] [Reference Citation Analysis]
|
| 70 |
Zhang T, Chen H, Zhang Y, Yin X, Man J, Yang X, Lu M. Global changing trends in incidence and mortality of gastric cancer by age and sex, 1990-2019: Findings from Global Burden of Disease Study. J Cancer 2021;12:6695-705. [PMID: 34659559 DOI: 10.7150/jca.62734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 71 |
Yang X, Zheng Y, Liu L, Huang J, Wang F, Zhang J. Progress on the study of the anticancer effects of artesunate. Oncol Lett 2021;22:750. [PMID: 34539854 DOI: 10.3892/ol.2021.13011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 72 |
Hu J, Yang S, Wang J, Zhang Q, Zhao L, Zhang D, Yu D, Jin M, Ma H, Liu H, Xue J, Zhang T. Blood alkaline phosphatase predicts prognosis of patients with advanced HER2-negative gastric cancer receiving immunotherapy. Ann Transl Med 2021;9:1316. [PMID: 34532453 DOI: 10.21037/atm-21-3376] [Reference Citation Analysis]
|
| 73 |
Xu S, Xiang C, Wu J, Teng Y, Wu Z, Wang R, Lu B, Zhan Z, Wu H, Zhang J. Tongue Coating Bacteria as a Potential Stable Biomarker for Gastric Cancer Independent of Lifestyle. Dig Dis Sci 2021;66:2964-80. [PMID: 33044677 DOI: 10.1007/s10620-020-06637-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 74 |
Hilal el idrissi H, Ennahal A. Association between DNMT3b 579G>T polymorphism and susceptibility to gastric cancer risk: A systematic review and an update meta-analysis. Meta Gene 2021;29:100928. [DOI: 10.1016/j.mgene.2021.100928] [Reference Citation Analysis]
|
| 75 |
Gullo I, Grillo F, Mastracci L, Vanoli A, Carneiro F, Saragoni L, Limarzi F, Ferro J, Parente P, Fassan M. Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes. Pathologica 2020;112:166-85. [PMID: 33179620 DOI: 10.32074/1591-951X-166] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 76 |
Cheng M, Hu J, Zhao Y, Jiang J, Qi R, Chen S, Li Y, Zheng H, Liu R, Guo Q, Zhang X, Qin Y, Hua B. Efficacy and Safety of Astragalus-Containing Traditional Chinese Medicine Combined With Platinum-Based Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis. Front Oncol 2021;11:632168. [PMID: 34422628 DOI: 10.3389/fonc.2021.632168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 77 |
Yang A, Liu X, Liu P, Feng Y, Liu H, Gao S, Huo L, Han X, Wang J, Kong W. LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis. Cell Mol Biol Lett 2021;26:33. [PMID: 34238213 DOI: 10.1186/s11658-021-00275-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 78 |
Zhou L, Jiang Z, Gu W, Han S. STROBE-clinical characteristics and prognosis factors of gastric cancer in young patients aged ≤30 years. Medicine (Baltimore) 2021;100:e26336. [PMID: 34190151 DOI: 10.1097/MD.0000000000026336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 79 |
Xu P, Xu X, Zhang L, Li Z, Qiang J, Yao J, Xu A. hsa_circ_0060975 is highly expressed and predicts a poor prognosis in gastric cancer. Oncol Lett 2021;22:619. [PMID: 34257727 DOI: 10.3892/ol.2021.12880] [Reference Citation Analysis]
|
| 80 |
Filho MFB, Santana MED, Mendes CP, Jesus Costa DD, Santos CAASD, Araújo MFMD, Oliveira Serra MAAD. Cultural, social, and healthcare access factors associated with delays in gastric cancer presentation, diagnosis, and treatment: A cross-sectional study. Journal of Cancer Policy 2021;28:100277. [DOI: 10.1016/j.jcpo.2021.100277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 81 |
Zeyaullah M, AlShahrani AM, Ahmad I. Association of Helicobacter pylori Infection and Host Cytokine Gene Polymorphism with Gastric Cancer. Can J Gastroenterol Hepatol 2021;2021:8810620. [PMID: 34136433 DOI: 10.1155/2021/8810620] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 82 |
Li H, Zhang X, Feng L. Ghrelin Regulates Cyclooxygenase-2 Expression and Promotes Gastric Cancer Cell Progression. Comput Math Methods Med 2021;2021:5576808. [PMID: 34122616 DOI: 10.1155/2021/5576808] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 83 |
Gingold-Belfer R, Kessler-Icekson G, Morgenstern S, Rath-Wolfson L, Zemel R, Boltin D, Levi Z, Herman-Edelstein M. The Transition from Gastric Intestinal Metaplasia to Gastric Cancer Involves POPDC1 and POPDC3 Downregulation. Int J Mol Sci 2021;22:5359. [PMID: 34069715 DOI: 10.3390/ijms22105359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 84 |
Wang J, Hou D, Peng Y, Xiong J, Xiong L, Tan X. Efficacy and safety of Xihuang pill for gastric cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e25726. [PMID: 34106598 DOI: 10.1097/MD.0000000000025726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 85 |
Guan B, Ma J, Yang Z, Yu F, Yao J. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling. Environ Toxicol 2021;36:1640-53. [PMID: 33974352 DOI: 10.1002/tox.23160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 86 |
Huo J, Wu L, Zang Y. Eight-gene prognostic signature associated with hypoxia and ferroptosis for gastric cancer with general applicability. Epigenomics 2021;13:875-90. [PMID: 33942671 DOI: 10.2217/epi-2020-0411] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 87 |
Mao L, Yuan W, Cai K, Lai C, Huang C, Xu Y, Zhong S, Yang C, Wang R, Zeng P, Huang H, Chen Z, Chen Z. EphA2-YES1-ANXA2 pathway promotes gastric cancer progression and metastasis. Oncogene 2021;40:3610-23. [PMID: 33941853 DOI: 10.1038/s41388-021-01786-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 88 |
Huo J, Wu L, Zang Y. Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer. J Immunol Res 2021;2021:5554342. [PMID: 34007851 DOI: 10.1155/2021/5554342] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 89 |
Huo J, Wu L, Zang Y. Eleven immune-gene pairs signature associated with TP53 predicting the overall survival of gastric cancer: a retrospective analysis of large sample and multicenter from public database. J Transl Med 2021;19:183. [PMID: 33926488 DOI: 10.1186/s12967-021-02846-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 90 |
Gao Q, Liu Q, Chen H. Circular RNA hsa_circ_0000117 accelerates the proliferation and invasion of gastric cancer cells by regulating the microRNA-337-3p/signal transducer and activator of transcription 3 axis. Bioengineered 2021;12:1381-90. [PMID: 33896365 DOI: 10.1080/21655979.2021.1918992] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 91 |
Zhang Y, Yan Y, Ning N, Shen Z, Ye Y. A signature of 24 aging‑related gene pairs predict overall survival in gastric cancer. Biomed Eng Online 2021;20:35. [PMID: 33823856 DOI: 10.1186/s12938-021-00871-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 92 |
Saito H, Nishikawa Y, Masuzawa Y, Tsubokura M, Mizuno Y. Helicobacter pylori Infection Mass Screening for Children and Adolescents: a Systematic Review of Observational Studies. J Gastrointest Cancer 2021;52:489-97. [PMID: 33761050 DOI: 10.1007/s12029-021-00630-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 93 |
Tay SW, Li JW, Fock KM. Diet and cancer of the esophagus and stomach. Curr Opin Gastroenterol 2021;37:158-63. [PMID: 33315794 DOI: 10.1097/MOG.0000000000000700] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 94 |
Zhang T, Chen H, Yin X, He Q, Man J, Yang X, Lu M. Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: Findings from Global Burden of Disease Study. Chin J Cancer Res 2021;33:11-26. [PMID: 33707924 DOI: 10.21147/j.issn.1000-9604.2021.01.02] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 95 |
Schütte K, Schulz C, Middelberg-Bisping K. Impact of gastric cancer treatment on quality of life of patients. Best Pract Res Clin Gastroenterol 2021;50-51:101727. [PMID: 33975681 DOI: 10.1016/j.bpg.2021.101727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 96 |
Auwercx J, Rybarczyk P, Kischel P, Dhennin-Duthille I, Chatelain D, Sevestre H, Van Seuningen I, Ouadid-Ahidouch H, Jonckheere N, Gautier M. Mg2+ Transporters in Digestive Cancers. Nutrients 2021;13:210. [PMID: 33450887 DOI: 10.3390/nu13010210] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 97 |
Yang Y, He W, Wang ZR, Wang YJ, Li LL, Lu JZ, Tao Y, Zhang J, Fu SJ, Wang ZP, Liu SH. Immune Cell Landscape in Gastric Cancer. Biomed Res Int 2021;2021:1930706. [PMID: 33575321 DOI: 10.1155/2021/1930706] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 98 |
Li M, Wang X, Liu J, Mao X, Li D, Wang Z, Tang Y, Wu S. Identification of Core Prognosis-Related Candidate Genes in Chinese Gastric Cancer Population Based on Integrated Bioinformatics. Biomed Res Int 2020;2020:8859826. [PMID: 33381592 DOI: 10.1155/2020/8859826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 99 |
Ren H, Zhu J, Yu H, Bazhin AV, Westphalen CB, Renz BW, Jacob SN, Lampert C, Werner J, Angele MK, Bösch F. Angiogenesis-Related Gene Expression Signatures Predicting Prognosis in Gastric Cancer Patients. Cancers (Basel) 2020;12:E3685. [PMID: 33302481 DOI: 10.3390/cancers12123685] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 100 |
Llorca-otero L, Toro-rueda C. Diagnosis of Helicobacter pylori infection: Progress and challenges. Enfermedades Infecciosas y Microbiología Clínica 2020;38:407-9. [DOI: 10.1016/j.eimc.2020.09.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 101 |
Llorca-otero L, Toro-rueda C. Diagnosis of Helicobacter pylori infection: Progress and challenges. Enfermedades infecciosas y microbiologia clinica (English ed ) 2020;38:407-409. [DOI: 10.1016/j.eimce.2020.09.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 102 |
Tao W, Wang HX, Guo YF, Yang L, Li P. Establish a Scoring Model for High-Risk Population of Gastric Cancer and Study on the Pattern of Opportunistic Screening. Gastroenterol Res Pract 2020;2020:5609623. [PMID: 33061960 DOI: 10.1155/2020/5609623] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 103 |
Demir AM, Berberoğlu Ateş B, Hızal G, Yaman A, Tuna Kırsaçlıoğlu C, Oğuz AS, Karakuş E, Yaralı N, Özbek NY. Autoimmune atrophic gastritis: The role of Helicobacter pylori infection in children. Helicobacter 2020;25:e12716. [PMID: 32589356 DOI: 10.1111/hel.12716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 104 |
Meng C, Xia S, He Y, Tang X, Zhang G, Zhou T. Discovery of Prognostic Signature Genes for Overall Survival Prediction in Gastric Cancer. Comput Math Methods Med 2020;2020:5479279. [PMID: 32908579 DOI: 10.1155/2020/5479279] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 105 |
Sharifi-Rad J, Rodrigues CF, Stojanović-Radić Z, Dimitrijević M, Aleksić A, Neffe-Skocińska K, Zielińska D, Kołożyn-Krajewska D, Salehi B, Milton Prabu S, Schutz F, Docea AO, Martins N, Calina D. Probiotics: Versatile Bioactive Components in Promoting Human Health. Medicina (Kaunas) 2020;56:E433. [PMID: 32867260 DOI: 10.3390/medicina56090433] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 15.3] [Reference Citation Analysis]
|
| 106 |
Zagari RM, Frazzoni L, Marasco G, Fuccio L, Bazzoli F. Treatment of Helicobacter pylori infection: a clinical practice update. Minerva Med 2021;112:281-7. [PMID: 32700868 DOI: 10.23736/S0026-4806.20.06810-X] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 107 |
Renzulli M, Clemente A, Spinelli D, Ierardi AM, Marasco G, Farina D, Brocchi S, Ravaioli M, Pettinari I, Cescon M, Reginelli A, Cappabianca S, Carrafiello G, Golfieri R. Gastric Cancer Staging: Is It Time for Magnetic Resonance Imaging? Cancers (Basel) 2020;12:E1402. [PMID: 32485933 DOI: 10.3390/cancers12061402] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 108 |
Arai H, Nakajima TE. Recent Developments of Systemic Chemotherapy for Gastric Cancer. Cancers (Basel) 2020;12:E1100. [PMID: 32354119 DOI: 10.3390/cancers12051100] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 109 |
Dimitroulis D, Garmpis N, Damaskos C. Surgical Strategies in the Era of SARS-CoV-2. Pan Afr Med J 2020;35:9. [PMID: 32528620 DOI: 10.11604/pamj.2020.35.2.22975] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
